These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12435517)
81. Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs. Brown TJ; McCrary M; Tyring SK J Am Acad Dermatol; 2002 Oct; 47(4):581-99. PubMed ID: 12271305 [TBL] [Abstract][Full Text] [Related]
82. Projections on the use of antiviral chemicals in animals. Gustafson DP J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1081-4. PubMed ID: 7216876 [No Abstract] [Full Text] [Related]
83. Bullous diseases: unapproved treatments or indications. Ruocco V; Ruocco E; Wolf R Clin Dermatol; 2000; 18(2):191-5. PubMed ID: 10742628 [No Abstract] [Full Text] [Related]
84. Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017. Yu J; Petrie ID; Levy RH; Ragueneau-Majlessi I Drug Metab Dispos; 2019 Feb; 47(2):135-144. PubMed ID: 30442649 [TBL] [Abstract][Full Text] [Related]
85. A drug is not a drug is not a drug: a commentary. Struijker Boudier HA Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):437-8. PubMed ID: 12426926 [No Abstract] [Full Text] [Related]
86. Cutaneous infections from viral sources in solid organ transplant recipients. Ilyas M; Maganty N; Sharma A J Clin Virol; 2017 Dec; 97():33-37. PubMed ID: 29096391 [TBL] [Abstract][Full Text] [Related]
87. The march toward rational therapeutics in children. Gorman RL Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584 [TBL] [Abstract][Full Text] [Related]
88. FDA panel rejects common cold treatment. Senior K Lancet Infect Dis; 2002 May; 2(5):264. PubMed ID: 12062983 [No Abstract] [Full Text] [Related]
89. [Herpes zoster in an infant without postnatal varicella infection]. Painsi C; Huegel R; Lange-Asschenfeldt B J Dtsch Dermatol Ges; 2016 Apr; 14(4):429-30. PubMed ID: 27018770 [No Abstract] [Full Text] [Related]
91. Antiviral therapies in children: has their time arrived? Kimberlin DW Pediatr Clin North Am; 2005 Jun; 52(3):837-67, vii. PubMed ID: 15925665 [TBL] [Abstract][Full Text] [Related]
92. Approval of a tuberculosis drug based on a paradoxical surrogate measure. Avorn J JAMA; 2013 Apr; 309(13):1349-50. PubMed ID: 23430122 [No Abstract] [Full Text] [Related]
93. New antiviral agents for dermatologic disease. Carlton S; Evans T; Tyring SK Semin Cutan Med Surg; 1998 Dec; 17(4):243-55. PubMed ID: 9859911 [TBL] [Abstract][Full Text] [Related]
94. Psychiatric promise: old drugs, new uses. Wick JY Am Pharm; 1993 Feb; NS33(2):47-56. PubMed ID: 8456746 [No Abstract] [Full Text] [Related]
95. The antiviral properties of vitamin C. Colunga Biancatelli RML; Berrill M; Marik PE Expert Rev Anti Infect Ther; 2020 Feb; 18(2):99-101. PubMed ID: 31852327 [No Abstract] [Full Text] [Related]
96. Within-Host Viral Dynamics in a Multi-compartmental Environment. Chen SS; Cheng CY; Rong L Bull Math Biol; 2019 Oct; 81(10):4271-4308. PubMed ID: 31432306 [TBL] [Abstract][Full Text] [Related]
97. Early phase dose-finding trials in virology. Dehbi HM; Lowe DM; O'Quigley J Stat Med; 2021 Jan; 40(2):240-253. PubMed ID: 33053601 [TBL] [Abstract][Full Text] [Related]